Wholesale UCT-MSC Stem Cells for Licensed Clinics

Wholesale UCT-MSC Stem Cells for Licensed Medical Professionals

Stem Nova Network supplies research-grade human umbilical cord tissue–derived mesenchymal stem cells (hUCT-MSCs) to licensed medical professionals nationwide. Every vial ships from an AATB-accredited, FDA-registered tissue establishment operating under cGTP-compliant standards (21 CFR Part 1271), with independent dual-lab Certificate of Analysis documentation and NTA particle verification per lot.

UCT-MSC products are not FDA-approved drugs or therapeutic agents. They are supplied as research-grade biologics for professional use. All clinical decisions are the sole responsibility of the licensed practitioner.

What Are UCT-MSCs?

Human umbilical cord tissue–derived mesenchymal stem cells (hUCT-MSCs) are isolated from the Wharton's Jelly layer of donated umbilical cord tissue following healthy, full-term births. As a perinatal cell source, UCT-MSCs are biologically young — they have not undergone the cumulative replication stress associated with adult-derived cell populations.

Mesenchymal stem cells are among the most widely studied cell types in regenerative science, with over 1,500 registered clinical trials listed on ClinicalTrials.gov evaluating UCT-MSCs across a range of investigational applications. Stem Nova supplies these cells in their research-grade form to qualified practitioners who make individualized clinical decisions under their own medical licensure.

Why Sourcing Standards Matter

Not all UCT-MSC products are manufactured the same way. The sourcing, culture method, and expansion protocol directly affect the biological characteristics of the final product. Here is how Stem Nova's manufacturing process differs from industry norms.

3D Bioreactor Culture vs. 2D Flask Expansion

Most tissue suppliers culture mesenchymal stem cells in flat, two-dimensional plastic flasks. Stem Nova's manufacturing partner uses 3D bioreactor systems that more closely replicate the native tissue microenvironment. Three-dimensional culture preserves cell morphology, surface marker expression, and paracrine output in ways that 2D flask systems do not replicate at scale.

Population Doublings: Why Fewer Is Better

Population doubling (PD) count measures how many times a cell population has divided during manufacturing. Every doubling introduces cumulative replication stress — telomere shortening, epigenetic drift, and increased senescence markers. Stem Nova's UCT-MSC vials are expanded to approximately 10 population doublings. Many competitors expand to 25–30 doublings to maximize yield from a single donor lot. The difference is logarithmic: cells at 25 PD have divided roughly 33 million times more than cells at 10 PD. Fewer doublings produce a biologically younger, less replication-aged cell population.

First-Pregnancy Donor Selection

Stem Nova sources exclusively from first-pregnancy donors who pass comprehensive medical history screening, infectious disease testing, and eligibility determination per FDA and AATB requirements. First-pregnancy cord tissue has not been exposed to the immunological priming associated with subsequent pregnancies.

Quality Verification & Regulatory Standards

Every Stem Nova UCT-MSC lot undergoes independent testing before release. No lot ships without meeting all release criteria — products that fail remain quarantined. This is a hard gate in the manufacturing process, not a sampling protocol.

Facility Credentials

AATB Accredited — The American Association of Tissue Banks sets the most rigorous voluntary standards for tissue banking in the United States
FDA-Registered Facility — Registered as a human cells, tissues, and cellular and tissue-based products (HCT/P) establishment
cGTP-Compliant (21 CFR Part 1271) — Current Good Tissue Practice compliance governs donor eligibility, processing, storage, labeling, and distribution
State Licensed — Licensed in all states requiring independent tissue establishment licensure

Per-Lot Testing

Dual-Lab COA Verification — Every lot is tested by both the manufacturing facility and an independent third-party laboratory. Dual-lab verification eliminates single-source reporting bias
Sterility Testing — 14-day USP sterility protocol (aerobic and anaerobic)
Endotoxin Screening — LAL kinetic turbidimetric assay, threshold <5 EU/mL
Mycoplasma Testing — qPCR-based detection, threshold ≤0.02
Comprehensive Viral Panel — HIV-1/2, Hepatitis B (HBsAg, anti-HBc), Hepatitis C, HTLV-I/II, Syphilis, CMV, and NAT testing
Cell Viability — ≥97% post-thaw viability verified per lot
Surface Marker Expression — 100% CD90 and CD166 expression confirmed by flow cytometry

COA documents are available for every lot upon request. Contact our team to request sample documentation before placing your first order.

Product Specifications

25M hUCT-MSC Vial

Cell Count: 25 million mesenchymal stem cells per vial
Source: Human umbilical cord tissue (Wharton's Jelly), first-pregnancy donors
Culture Method: 3D bioreactor, xeno-free (no animal serum)
Population Doublings: ~10 PD (vs. industry standard 25–30 PD)
Storage: Cryopreserved in LN₂ vapor phase ≤ −140°C
Post-Thaw Viability: ≥97%
Volume: 1 mL per vial
Classification: Research-grade biologic — not an FDA-approved drug or therapeutic agent

Wholesale pricing is available exclusively to credentialed medical professionals. Complete your enrollment application to access pricing and place orders.

Practice Verticals Using UCT-MSC Biologics

Licensed medical professionals across multiple specialties incorporate UCT-MSC biologics into individualized patient protocols under their own clinical judgment. Stem Nova supplies practitioners in the following verticals — all clinical decision-making remains the sole responsibility of the licensed provider.

Orthopedic & Pain Management Practices

Orthopedic surgeons and pain management physicians represent the largest clinical user base for UCT-MSC biologics in the United States. These practitioners make individualized decisions about regenerative biologic protocols within their scope of practice. Learn more about biologics for orthopedic practices.

Hair Restoration Clinics

Hair restoration specialists integrate UCT-MSC biologics into individualized patient protocols alongside their existing procedural workflows. Learn more about biologics for hair restoration.

Medspas & Aesthetic Practices

Medical spas and aesthetic practices use topical exosome biologics and UCT-MSC products as part of individualized cosmetic protocols. Stem Nova supplies both product categories, allowing practices to build a comprehensive biologics menu. Learn more about biologics for medspas.

Wellness & Longevity Practices

Functional medicine, anti-aging, and longevity-focused practices incorporate UCT-MSC biologics into individualized patient consultations. Learn more about biologics for wellness practices.

Dental & Periodontal Practices

Dental professionals explore regenerative biologics for individualized applications within their scope of practice. Learn more about biologics for dental practices.

How to Get Started

Stem Nova Network supplies UCT-MSC biologics exclusively to credentialed medical professionals. Here is how the enrollment process works:

Submit Your Application — Complete the wholesale enrollment application with your medical credentials and practice information
Credential Verification — Our team verifies your active medical license, DEA registration (if applicable), and practice details. Verification typically completes within 1–2 business days
Account Activation — Once approved, you receive wholesale pricing access, COA documentation, and dedicated account support
Place Your First Order — Orders ship via cold-chain logistics in validated cryoshippers. Every shipment includes lot-specific COA documentation

Questions before applying? Contact our team or call to speak with a product specialist.

Frequently Asked Questions

Are UCT-MSC stem cells FDA approved?

No. UCT-MSC products are not FDA-approved drugs or therapeutic agents. The only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood for limited hematopoietic indications. Stem Nova's UCT-MSC vials are supplied as research-grade biologics from an FDA-registered, AATB-accredited facility operating under cGTP-compliant standards (21 CFR Part 1271). All clinical decisions regarding use are individualized and remain the sole responsibility of the licensed practitioner.

What is the difference between FDA registration and FDA approval?

FDA registration means the manufacturing facility is registered with the FDA as an HCT/P establishment and complies with applicable regulations under 21 CFR Part 1271. FDA approval refers to a specific drug or biologic product that has undergone clinical trials and received marketing authorization. Stem Nova's facility is FDA-registered; the products themselves are not FDA-approved drugs.

What makes Stem Nova's UCT-MSCs different from other suppliers?

Three primary differentiators: (1) 3D bioreactor culture instead of standard 2D flask expansion, (2) approximately 10 population doublings versus the industry-standard 25–30, producing a less replication-aged cell population, and (3) independent dual-lab COA verification with NTA particle analysis on every lot — not batch sampling or in-house-only testing.

What is a Certificate of Analysis (COA)?

A COA is a document that reports the results of quality testing performed on a specific manufacturing lot. Stem Nova provides dual-lab COAs — testing performed by both the manufacturing facility and an independent third-party laboratory — covering sterility, endotoxin, mycoplasma, viral screening, viability, and cell surface marker expression. Sample COAs are available upon request before your first order.

How are UCT-MSC vials shipped?

All UCT-MSC products ship in validated cryoshippers that maintain liquid nitrogen vapor phase temperatures (≤ −140°C) throughout transit. Shipments include temperature monitoring and lot-specific documentation.

What is the minimum order?

There is no minimum order requirement. Wholesale pricing applies to all approved accounts regardless of volume. Volume-based pricing tiers are available for practices with recurring needs.

Do you provide clinical training or protocols?

Stem Nova provides product handling documentation, thawing protocols, and storage guidelines. All clinical protocols and treatment decisions are individualized by the licensed practitioner. Stem Nova does not prescribe, recommend, or endorse specific clinical protocols. Practitioners should consult with their own medical advisors and comply with applicable federal and state regulations.

For licensed professional use only. Not intended to diagnose, treat, cure, or prevent any disease. These products are not FDA-approved drugs or therapeutic agents. All clinical decisions are the sole responsibility of the licensed practitioner. Consult your primary care provider for medical advice.